glutathione-related factors and oxidative stress in autism a review Frontiers A model for the induction
Description
The chronic nature of Noopept benefits (strengthening over 28 days without tolerance) complements the more acute effects of Semax
Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab
Nucleus 4 , 7482 (2013)
doi: 10.1136/bmj.316.7135.894
